美好医疗：关于更换持续督导保荐代表人的公告

Core Viewpoint - Meihao Medical announced a change in its continuous supervision representative from Dongxing Securities due to the work shift of the original representative [2] Group 1 - Meihao Medical received a notification from Dongxing Securities regarding the replacement of the continuous supervision representative [2] - Dongxing Securities is the sponsor for Meihao Medical's initial public offering and is currently fulfilling its continuous supervision responsibilities [2] - The statutory period for continuous supervision for the IPO project will last until December 31, 2025 [2] Group 2 - The original representatives, Mr. Li Jingyu and Mr. Wei Jiequan, were responsible for the continuous supervision work [2] - Mr. Li Jingyu will no longer be responsible for the project due to a work change [2] - Mr. Wu Shidi has been appointed to take over the continuous supervision responsibilities [2]